Dr. Nancy Sacco is currently VP, Head of Clinical Operations at SiteBridge Research. With more than 20 years of pharmaceutical and drug development experience, spanning phase 1-4 clinical studies, she has helped global clinical development in leadership roles at Xentria, AnaptysBio, Revance, AveXis, Astellas, Takeda, Pfizer, and Procter and Gamble Healthcare. Nancy has been involved in more than 30 IND and several ODAs for rare diseases, pivotal trials for dermatologic and respiratory diseases, and more than a dozen NDAs/MAAs/BLAs for various therapeutic products (DaxibotulinumtoxinA, ZolgenSMA, Myrbetriq, XTandi, Rozerem, Cresemba, ACTOS, Lipitor, Lyrica, Actonel) over the course of her career.